...
首页> 外文期刊>Biopharmaceutics and Drug Disposition >Primaquine disposition in the isolated perfused rat liver: Effect of mefloquine induced bile flow reduction
【24h】

Primaquine disposition in the isolated perfused rat liver: Effect of mefloquine induced bile flow reduction

机译:Primaquine disposition in the isolated perfused rat liver: Effect of mefloquine induced bile flow reduction

获取原文

摘要

AbstractThe disposition of primaquine (0·75 mg, 5 μCi) has been investigated in the isolated perfused rat liver (IPRL) preparation alone and concurrently with mefloquine. In both groups, primaquine concentrations declined exponentially. There were no significant differences between the respective groups in the half‐lives (2·5 ± 1·5, 2·2 ± 1·1 h), AUCs (0·43 ± 0·14, 0·372 ± 0·096 μg·h ml−1), clearances (19·0 ± 5·4, 21·1 ± 4·2 ml h−1), and apparent volume of distribution (78·9 ± 28·1, 76·2 ± 31·7 ml). In the presence of mefloquine, total bile production was significantly reduced (1244·5 ± 317·1 μl) compared with primaquine alone (1621·5 ± 174·2 μl). Hence, although significantly less radioactivity (3H) was eliminated in bile in the presence of mefloquine (30·0 ± 7·9 per cent versus 39·9 ± 3·6 per cent) there was no significant difference between the groups in 3H/μl bile eliminated. Significantly more 3H was recovered from the livers of the mefloquine/primaquine group. This was underlined by the significantly greater proportions of 3H recovered from the 10000 g pellet, 10000 g supernatant and 105000 g supernatant in the presence of mefloquine compared with primaquine alone. Hence, it appears mefloquine had little or no direct action or primaquine metab

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号